What is the purpose of the Bortetrust 2 Bortezomib 2mg Injection?
Bortetrust 2 Bortezomib 2mg Injection is a drug that is used to treat multiple myeloma, a type of cancer of the bone marrow. Bortezomib is also used to treat patients with mantle cell lymphoma, fast-growing cancer that begins in the cells of the immune system. Bortezomib belongs to the class of medicines known as antineoplastic agents.
Is bortezomib a type of chemotherapy?
Velcade (bortezomib) is a targeted therapy, which is a kind of chemotherapy. Velcade is a proteasome inhibitor, which is a type of medication. The FDA has given it the approval to treat multiple myeloma and mantle cell lymphoma.
What is the most extreme measure of time you can take Bortezomib?
Bortezomib can be utilized alone assuming you’ve proactively had myeloma treatment. Bortezomib is usually used for two weeks at a time. After that, you’ll have a ten-day relaxation period. A treatment cycle is a three-week treatment phase.
What are the Bortetrust 2 Bortezomib 2mg Injection side effects?
- The infusion site might cause wooziness.
- An absence of craving
- the runs
- or torment/redness.
- Sickness, regurgitating
- and loose bowels are
- On the whole, normal secondary effects.
- Your primary care physician might prescribe medicine to forestall or mitigate queasiness.
- heaving, or the runs in certain conditions.
For more details Click Here.
Is Bortetrust 2 Bortezomib Injection associated with hair loss?
Hair loss is a common occurrence. Hair loss isn’t a known side effect of Velcade, although it could be brought on by other medications you’re taking. Individuals utilizing Velcade in addition to the cytotoxic prescription cyclophosphamide, for instance, may experience going bald.
What is the best way to administer a Bortetrust 2 Bortezomib 2mg Injection?
At least 72 hours should pass between successive bortezomib doses. Bortezomib 2.5 mg/ml Solution for Injection is injected into the thighs (right or left) or belly subcutaneously (right or left). Subcutaneous injections at a 45-90° angle are recommended.
How frequently is Bortezomib 2 mg injection administered?
VELCADE is given two times week after week for two weeks (Days 1, 4, 8, and 11), then, at that point, a ten-dawn from Days 12 to 21. Two further VcR-CAP cycles are advised for patients who had a response to Cycle 6. At least 72 hours should pass between successive VELCADE doses.